Research ArticleArticle
Gene Variants in CYP2C19 are Associated with Altered In Vivo Bupropion Pharmacokinetics but not Bupropion Assisted Smoking Cessation Outcomes
Andy Z.X. Zhu, Qian Zhou, Lisa Sanderson Cox, Jasjit S. Ahluwalia, Neal L. Benowitz and Rachel F. Tyndale
Drug Metabolism and Disposition September 3, 2014, dmd.114.060285; DOI: https://doi.org/10.1124/dmd.114.060285
Andy Z.X. Zhu
1 University of Toronto;
Qian Zhou
1 University of Toronto;
Lisa Sanderson Cox
2 University of Kansas School of Medicine;
Jasjit S. Ahluwalia
3 University of Minnesota Medical School;
Neal L. Benowitz
4 University of California, San Francisco
Rachel F. Tyndale
1 University of Toronto;
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Gene Variants in CYP2C19 are Associated with Altered In Vivo Bupropion Pharmacokinetics but not Bupropion Assisted Smoking Cessation Outcomes
Andy Z.X. Zhu, Qian Zhou, Lisa Sanderson Cox, Jasjit S. Ahluwalia, Neal L. Benowitz and Rachel F. Tyndale
Drug Metabolism and Disposition September 3, 2014, dmd.114.060285; DOI: https://doi.org/10.1124/dmd.114.060285
Research ArticleArticle
Gene Variants in CYP2C19 are Associated with Altered In Vivo Bupropion Pharmacokinetics but not Bupropion Assisted Smoking Cessation Outcomes
Andy Z.X. Zhu, Qian Zhou, Lisa Sanderson Cox, Jasjit S. Ahluwalia, Neal L. Benowitz and Rachel F. Tyndale
Drug Metabolism and Disposition September 3, 2014, dmd.114.060285; DOI: https://doi.org/10.1124/dmd.114.060285
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement